UK Early Access Scheme 'A Success,' But Industry Wants Improvements

 
• By Leela Barham

Launched in April 2014, the UK’s Early Access to Medicines Scheme has delivered pre-approval patient access to many treatments for life-threatening and seriously debilitating conditions. But after 10 years of the EAMS, the pharmaceutical industry wants new guidance and says the scheme should evolve so that companies can make the most of the opportunity it offers in the future.

doctor prescribing medicine sitting at the desk in the clinic office
The EAMS has allowed early patient access to many new medicines • Source: Shutterstock

More from Europe

More from Geography